NKI

Functional genomics for rational tumor and immune cell combination therapy

Leiden University

Drug discovery – Novel chemical modalities – Nucleic acid binding proteins

Princess Máxima Center

Cancer, immunotherapy development, high resolution 3D imaging, organoid technology, bio-engineering

Erasmus MC

Hematopoietic stem cells; leukemia; bone marrow failure; myelodysplastic syndrome; myeloproliferative neoplasms; genetic fate tracing; CRISPR-Cas9; scRNA sequencing